DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,470,948 | +3.8% | 147,001 | +0.4% | 4.42% | +8.4% |
| Q2 2023 | $35,136,240 | -5.5% | 146,401 | -0.8% | 4.08% | -10.2% |
| Q1 2023 | $37,187,746 | -7.5% | 147,547 | -2.5% | 4.55% | -11.0% |
| Q4 2022 | $40,182,199 | +1.0% | 151,391 | -1.7% | 5.10% | -4.1% |
| Q3 2022 | $39,771,000 | -3.1% | 153,977 | -4.9% | 5.32% | +5.2% |
| Q2 2022 | $41,033,000 | -15.3% | 161,852 | -2.0% | 5.06% | +3.7% |
| Q1 2022 | $48,442,000 | -11.6% | 165,145 | -0.9% | 4.88% | -5.6% |
| Q4 2021 | $54,815,000 | +9.5% | 166,607 | +1.3% | 5.17% | -0.8% |
| Q3 2021 | $50,073,000 | +12.0% | 164,477 | -1.3% | 5.21% | +11.6% |
| Q2 2021 | $44,720,000 | +20.2% | 166,642 | +0.8% | 4.67% | +8.7% |
| Q1 2021 | $37,206,000 | +0.2% | 165,302 | -1.1% | 4.29% | -3.2% |
| Q4 2020 | $37,129,000 | -1.8% | 167,142 | -4.8% | 4.44% | -5.1% |
| Q3 2020 | $37,791,000 | +21.0% | 175,502 | -0.7% | 4.68% | +7.9% |
| Q2 2020 | $31,245,000 | +27.7% | 176,697 | -0.1% | 4.33% | +6.7% |
| Q1 2020 | $24,470,000 | -9.4% | 176,797 | +0.4% | 4.06% | +15.3% |
| Q4 2019 | $27,020,000 | +5.1% | 176,052 | -1.1% | 3.52% | -3.6% |
| Q3 2019 | $25,711,000 | +0.2% | 178,017 | -0.9% | 3.66% | +4.5% |
| Q2 2019 | $25,665,000 | +7.1% | 179,577 | -1.1% | 3.50% | +4.4% |
| Q1 2019 | $23,965,000 | +25.0% | 181,527 | -2.4% | 3.35% | +9.2% |
| Q4 2018 | $19,173,000 | -4.2% | 185,927 | +1.0% | 3.07% | +13.4% |
| Q3 2018 | $20,013,000 | +10.1% | 184,177 | -0.0% | 2.70% | +1.9% |
| Q2 2018 | $18,180,000 | +0.5% | 184,227 | -0.3% | 2.65% | -2.4% |
| Q1 2018 | $18,084,000 | +4.6% | 184,702 | -0.8% | 2.72% | +7.0% |
| Q4 2017 | $17,284,000 | +6.4% | 186,212 | -1.7% | 2.54% | +0.7% |
| Q3 2017 | $16,241,000 | +14.1% | 189,337 | +12.2% | 2.52% | +13.2% |
| Q2 2017 | $14,237,000 | +1.7% | 168,707 | +3.1% | 2.23% | -3.0% |
| Q1 2017 | $14,000,000 | +10.2% | 163,682 | +0.3% | 2.30% | -0.3% |
| Q4 2016 | $12,702,000 | -2.3% | 163,182 | -1.6% | 2.30% | -2.0% |
| Q3 2016 | $12,998,000 | -22.6% | 165,807 | -0.3% | 2.35% | -20.4% |
| Q2 2016 | $16,802,000 | +6.3% | 166,357 | -0.2% | 2.95% | +0.8% |
| Q1 2016 | $15,811,000 | +3.7% | 166,672 | +1.6% | 2.93% | +2.4% |
| Q4 2015 | $15,244,000 | +9.0% | 164,122 | +0.0% | 2.86% | +5.8% |
| Q3 2015 | $13,982,000 | +0.7% | 164,090 | +1.1% | 2.70% | +7.0% |
| Q2 2015 | $13,886,000 | +3.9% | 162,235 | +3.1% | 2.53% | +1.3% |
| Q1 2015 | $13,362,000 | -1.0% | 157,385 | -0.0% | 2.49% | +3.1% |
| Q4 2014 | $13,494,000 | +13.7% | 157,435 | +0.8% | 2.42% | +5.1% |
| Q3 2014 | $11,868,000 | +9.7% | 156,205 | +13.7% | 2.30% | +9.9% |
| Q2 2014 | $10,816,000 | +9.3% | 137,380 | +4.1% | 2.09% | +2.1% |
| Q1 2014 | $9,900,000 | -1.0% | 132,005 | +1.9% | 2.05% | -0.4% |
| Q4 2013 | $10,000,000 | +11.9% | 129,530 | +0.5% | 2.06% | -0.2% |
| Q3 2013 | $8,937,000 | +8.9% | 128,930 | -0.5% | 2.06% | +6.2% |
| Q2 2013 | $8,206,000 | – | 129,630 | – | 1.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |